Search

everythinglearnresearchcommunity

for

Search:↓

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

Higher levels of the DP2 receptor may lead to hair loss.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

PGD2 stops hair growth and is higher in bald men with AGA.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

Higher DHT in male baldness may protect against prostate cancer.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Targeting CXXC5 and GSK-3β may help treat male pattern baldness.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

The leaf extract of Leea indica may reduce inflammation, dissolve blood clots, and promote hair growth.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

No genetic link between prostaglandins and hair loss found.

Personalized treatments for hair loss are becoming more effective by using genetic information.